Astesana V - Search Results

1

Correction to: [Pt(O,O'-acac)(γ-acac)(DMS)]: Alternative Strategies to Overcome Cisplatin-Induced Side Effects and Resistance in T98G Glioma Cells.

Astesana V, Faris P, Ferrari B, Siciliani S, Lim D, Biggiogera M, De Pascali SA, Fanizzi FP, Roda E, Moccia F, Bottone MG. Astesana V, et al. Cell Mol Neurobiol. 2021 Apr;41(3):589. doi: 10.1007/s10571-020-00896-1. Cell Mol Neurobiol. 2021. PMID: 32535721 No abstract available.

2

[Pt(O,O'-acac)(γ-acac)(DMS)]: Alternative Strategies to Overcome Cisplatin-Induced Side Effects and Resistance in T98G Glioma Cells.

Astesana V, Faris P, Ferrari B, Siciliani S, Lim D, Biggiogera M, De Pascali SA, Fanizzi FP, Roda E, Moccia F, Bottone MG. Astesana V, et al. Cell Mol Neurobiol. 2021 Apr;41(3):563-587. doi: 10.1007/s10571-020-00873-8. Epub 2020 May 19. Cell Mol Neurobiol. 2021. PMID: 32430779

3

A new platinum-based prodrug candidate: Its anticancer effects in B50 neuroblastoma rat cells.

Rangone B, Ferrari B, Astesana V, Masiello I, Veneroni P, Zanellato I, Osella D, Bottone MG. Rangone B, et al. Among authors: astesana v. Life Sci. 2018 Oct 1;210:166-176. doi: 10.1016/j.lfs.2018.08.048. Epub 2018 Aug 23. Life Sci. 2018. PMID: 30144454

4

Metabolic vulnerability of cisplatin-resistant cancers.

Obrist F, Michels J, Durand S, Chery A, Pol J, Levesque S, Joseph A, Astesana V, Pietrocola F, Wu GS, Castedo M, Kroemer G. Obrist F, et al. Among authors: astesana v. EMBO J. 2018 Jul 13;37(14):e98597. doi: 10.15252/embj.201798597. Epub 2018 Jun 6. EMBO J. 2018. PMID: 29875130 Free PMC article.

5

Metabolic features of cancer cells impact immunosurveillance.

Joseph A, Juncheng P, Mondini M, Labaied N, Loi M, Adam J, Lafarge A, Astesana V, Obrist F, Klein C, Bloy N, Stoll G, Signolle N, Genestie C, Damotte D, Alifano M, Leary A, Pautier P, Morice P, Gouy S, Deutsch E, Chargari C, Dieu-Nosjean MC, Cremer I, Michels J, Kroemer G, Castedo M. Joseph A, et al. Among authors: astesana v. J Immunother Cancer. 2021 Jun;9(6):e002362. doi: 10.1136/jitc-2021-002362. J Immunother Cancer. 2021. PMID: 34162714 Free PMC article.

6

Correlation of TP53 and MDM2 genotypes and clinical outcome in platinum-treated head and neck cancer patients with more than 10 years' follow-up.

Vivenza D, Monteverde M, Lattanzio L, Tonissi F, Astesana V, Denaro N, Comino A, Russi E, Lo Nigro C, Merlano M. Vivenza D, et al. Among authors: astesana v. Int J Biol Markers. 2016 May 28;31(2):e183-92. doi: 10.5301/jbm.5000192. Int J Biol Markers. 2016. PMID: 26916894 Free article.

7

E1 detection as prognosticator in human papillomavirus-positive head and neck cancers.

Vivenza D, Lo Nigro C, Denaro N, Fortunato M, Monteverde M, Tonissi F, Lattanzio L, Astesana V, Gloghini A, Volpi CC, Russi E, Merlano MC. Vivenza D, et al. Among authors: astesana v. Int J Biol Markers. 2016 Apr-Jun;31(2):0. doi: 10.5301/jbm.5000193. Epub 2016 Mar 22. Int J Biol Markers. 2016. PMID: 27040135 Free article.

8

Reoxygenation Reverses Hypoxia-related Radioresistance in Head and Neck Cancer Cell Lines.

Tonissi F, Lattanzio L, Astesana V, Cavicchioli F, Ghiglia A, Monteverde M, Vivenza D, Gianello L, Russi E, Merlano M, Lo Nigro C. Tonissi F, et al. Among authors: astesana v. Anticancer Res. 2016 May;36(5):2211-5. Anticancer Res. 2016. PMID: 27127125

9

Prognostic Value of Different Allelic Polymorphism of Aldosterone Synthase Receptor in a Congestive Heart Failure European Continental Ancestry Population.

Feola M, Monteverde M, Vivenza D, Testa M, Leto L, Astesana V, Mussapi F, Vado A, Merlano M, Lo Nigro C. Feola M, et al. Among authors: astesana v. Arch Med Res. 2017 Feb;48(2):156-161. doi: 10.1016/j.arcmed.2017.03.008. Arch Med Res. 2017. PMID: 28625318

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page